New Journey(SZ:002219) Sou Hu Cai Jing·2025-09-10 06:16Core Insights - Neuralink, founded by Elon Musk, focuses on developing brain-computer interface (BCI) technology to treat various neurological issues, including blindness and mental disorders [3][4] - The company announced that 12 patients globally have used its brain implant devices for a total of over 2,000 days, accumulating 15,335 hours of usage, marking a significant milestone in long-term human use of BCI technology [3] - The first public trial participant, Noland Arbaugh, who became paralyzed from the waist down after a swimming accident in 2016, has resumed playing video games and learning languages after receiving the Neuralink implant, highlighting the technology's potential to restore lost functions [3] - Neuralink has made progress in international trials, completing its first overseas surgeries in Toronto, Canada, as part of a four-year clinical trial to assess whether quadriplegic patients can control electronic devices through thought [3] - In addition to Canada, Neuralink is conducting the GB-PRIME clinical study in the UK, which has received regulatory approval to evaluate how paralyzed patients can interact with the digital world using the implanted device, indicating the company's acceleration of global expansion and technology validation [4] - Elon Musk aims to reduce the cost of BCI devices and surgeries to a few thousand dollars to make the technology accessible to more people, and since receiving FDA approval for human trials in 2023, Neuralink has been expanding its trial scale [4]